GTCBIO ANNOUNCES ITS INAUGURAL CNS DISEASES PARTNERING & DEAL-MAKING SUMMIT
GTCbio announced its Inaugural CNS Partnering & Deal-Making Summit being held on December 1-2, 2008 in Boston, MA


    MONROVIA, CA, November 07, 2008 /Pharmaceutical News Articles/ -- This event is one of the leading CNS disease partnering forums bringing together members of government, industry and academia to discuss the latest advancements in the field. Leaders in business development and CNS diseases will present on new advancements in CNS disease research and development including recent deals and collaborations, R&D models and new technologies.
This very specialized summit takes a microscopic look at trends and developments in CNS diseases, from cutting-edge CNS disease research to early and late stage partnerships. This conference helps its delegates grasp a full scope of the market for new treatments and therapies for all types of CNS diseases.
A Joint featured presentation will be given by Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough. The presentation is entitled: CNS Deal Outlook: What We Can Learn from Recent Trends.

For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=140.

Further Related Resources:


Press Release Contact Information:

Rania Hafez
GTCbio
Marketing Director
434 W. Foothill Blvd.
Monrovia, CA
USA 91106
Voice: 626-256-6405
Fax: 626-256-6460
Website: Visit Our Website